Recent Updates
Recently added Catalysts
QTRX Positive Sentiment

Quanterix Names Jim Gute Chief Commercial Officer

Monday, August 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Quanterix Corporation has appointed Jim Gute as Chief Commercial Officer. Gute, a seasoned healthcare executive, will oversee the company's commercial operations and drive growth, particularly in diagnostics. The leadership change comes at a crucial time as Quanterix aims to expand its market presence.

Market Sentiment Analysis

POSITIVE FACTORS

  • Jim Gute brings extensive experience to Quanterix.
  • His appointment is expected to accelerate growth.
  • The company is focusing on expansion in diagnostics.

Full Press Release Details

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that seasoned healthcare executive Jim Gute has been appointed Chief Commercial Officer of the company. In this role, he will lead a re-acceleration of growth within the company’s commercial operations. “We are thrilled to attract commercial leadership of Jim’s caliber to Quanterix, at a pivotal time, ahead of our expansion in diagnostics and with renewed focu

Frequently Asked Questions

Who is the new Chief Commercial Officer of Quanterix?

Jim Gute has been appointed as the Chief Commercial Officer.

What will Jim Gute focus on at Quanterix?

He will lead the re-acceleration of growth in the company's commercial operations.

Why is Jim Gute's appointment significant?

His leadership comes at a pivotal time for Quanterix's expansion in diagnostics.

ShareAdd on Google
Tags: QTRX Viatris Investor Conferences Healthcare Quanterix Jim Gute Chief Commercial Officer biomarker science diagnostics
Last updated: Aug 10, 2026

Biotech snapshot

Cash runway
$99M liquidity · $6M/mo burn
~13 mo
Low dilution risk